Secondary prevention of ischemic stroke in Urban China

Stroke

Volumn 41, Issue 5, 2010, Pages 967-974

  Wei, Jade W ^a   Wang, Ji Guang ^b   Huang, Yining ^c   Liu, Ming ^d   Wu, Yangfeng ^e   Wong, Lawrence K S ^f   Cheng, Yan ^g   Xu, En ^h   Yang, Qidong ⁱ   Arima, Hisatomi ^a   Heeley, Emma L ^a   Anderson, Craig S ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c PEKING UNIVERSITY FIRST HOSPITAL   (China)

^d SICHUAN UNIVERSITY   (China)

^e PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^f CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^g TIANJIN MEDICAL UNIVERSITY   (China)

^h GUANGZHOU MEDICAL UNIVERSITY   (China)

ⁱ CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

China; Prevention; Stroke

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; WARFARIN;

ACUTE DISEASE; ADULT; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHINA; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL DISCHARGE; HOSPITAL PATIENT; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBESITY; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECONDARY PREVENTION; URBAN POPULATION;

AGED; BRAIN ISCHEMIA; CHINA; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REGISTRIES; RISK FACTORS; SECONDARY PREVENTION; STROKE; URBAN HEALTH;

EID: 77951768266     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.571463     Document Type: Article

References (27)

1. Liu M, Wu B, Wang WZ, Lee LM, Zhang SH, Kong LZ. Stroke in China: epidemiology, prevention, and management strategies. Lancet Neurol. 2007;6:456-464. (Pubitemid 46551849)
2. He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, Wang J, Chen CS, Chen J, Wildman RP, Klag MJ, Whelton PK. Major causes of death among men and women in China. N Engl J Med. 2005;353:1124-1134. (Pubitemid 41317435)
3. Hardie K, Hankey GJ, Jamrozik K, Broadhurst RJ, Anderson C. Ten-year risk of first recurrent stroke and disability after first-ever stroke in the Perth Community Stroke Study. Stroke. 2004;35:731-735. (Pubitemid 38280850)
4. Lin Y, Li YS, Xu Q, Shi GW, Li HW, Geng JL. [The impact of stroke clinic on improving the compliance with the guidelines for secondary prevention of ischemic stroke.] Zhonghua Nei Ke Za Zhi. 2007;46:73-79.
5. Ma R, Wang C, Zhao X, Xu M, Lv Y, Wei M, Cai Y, Zhang Z, Wang L, Zhang W, Huang Y, Li Y, Li H, Wang Y. A survey on compliance with secondary stroke prevention guidelines and follow up for the inpatients with atherosclerotic cerebral infarction/transient ischemic attack. Neurol Res. 2008;30:383-388. (Pubitemid 351881291)
6. Wang Y, Wu D, Ma R, Wang C, Zhao W. A survey on adherence to secondary ischemic stroke prevention. Neurol Res. 2006;28:16-20. (Pubitemid 43204489)
7. Wang Y, Wu D, Zhou Y, Zhao X, Wang C, Liu L, Liao X. Survey of blood pressure control status in patients with ischemic stroke or transient ischemic attack in China. Neurol Res. 2008;30:348-355. (Pubitemid 351881285)
8. Wu D, Ma RH, Wang YL, Wang YJ. [A study on drug compliance in secondary prevention of ischemic stroke.] Zhonghua Nei Ke Za Zhi. 2005;44:506-508.
9. Luk HH, Pang J, Li LS, Ng M. Use of antiplatelet drugs in the stroke unit of a Hong Kong hospital. Pharm World Sci. 2005;27:258-262. (Pubitemid 41159979)
10. Jiang B, Wang WZ, Wu SP, Du XL, Bao QJ. Effects of urban community intervention on 3-year survival and recurrence after first-ever stroke. Stroke. 2004;35:1242-1247. (Pubitemid 38697435)
11. Ke XJ, Yu YF, Guo ZL, Xu K, Hai H, Zhang AH, Jiang H, Peng H. The utilization status of aspirin for the secondary prevention of ischemic stroke. Chin Med J (Engl). 2009;122:165-168.
12. Heeley EP, Anderson CS, Huang Y, Jan SP, Li Y, Liu M, Sun J, Xu E, Wu YP, Yang Q, Zhang J, Zhang S, Wang J. for the ChinaQUEST Investigators. Role of health insurance in averting economic hardship in families after acute stroke in China. Stroke. 2009;40:2149-2156
13. Chinese Centre for Disease Control, Chinese Medical Association Neurology Division. China Guideline for Cerebrovascular Disease Prevention and Treatment. In: Rao ML, ed. Beijing, China: People's Medical Publishing House; 2007.
14. Zhou BF. Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases: report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults. Biomed Environ Sci. 2002;15:245-252.
15. National Bureau of Statistics of China. China Statistical Yearbook 2007. China Statistics Press 2007 [cited 2009 March 29]. Available at: http://www.stats.gov.cn/tjsj/ndsj/2007/indexee.htm.
16. Simpson CR, Wilson C, Hannaford PC, Williams D. Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care. Stroke. 2005;36:1771-1775. (Pubitemid 41098777)
17. Tuhrim S, Cooperman A, Rojas M, Brust JC, Koppel B, Martin K, Chassin M. The association of race and sex with the underuse of stroke prevention measures. J Stroke Cerebrovasc Dis. 2008;17:226-234. (Pubitemid 351858613)
18. Vergouwen MDI, de Haan RJ, Vermeulen M, Roos YBWEM. Statin treatment and the occurrence of hemorrhagic stroke in patients with a history of cerebrovascular disease. Stroke. 2008;39:497-502. (Pubitemid 351619482)
19. Sappok T, Faulstich A, Stuckert E, Kruck H, Marx P, Koennecke HC. Compliance with secondary prevention of ischemic stroke: a prospective evaluation. Stroke. 2001;32:1884-1889. (Pubitemid 32772225)
20. Hamann GF, Weimar C, Glahn J, Busse O, Diener HC. Adherence to secondary stroke prevention strategies: results from the German Stroke Data Bank. Cerebrovasc Dis. 2003;15:282-288. (Pubitemid 36438733)
21. Lummis HL, Sketris IS, Gubitz GJ, Joffres MR, Flowerdew GJ. Medication persistence rates and factors associated with persistence in patients following stroke: a cohort study. BMC Neurol. 2008;8:25.
22. Adams RJ, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Sacco RL, Schwamm LH. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack. Stroke. 2008;39:1647-1652.
23. Sacco RL, Adams R, Albers G, Alberts MJ, Benavente O, Furie K, Goldstein LB, Gorelick P, Halperin J, Harbaugh R, Johnston SC, Katzan I, Kelly-Hayes M, Kenton EJ, Marks M, Schwamm LH, Tomsick T. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: The Am Academy of Neurology affirms the value of this guideline. Stroke. 2006;37:577-617. (Pubitemid 43732031)
24. Klungel OH, de Boer A, Paes AH, Herings RM, Seidell JC, Bakker A. Agreement between self-reported antihypertensive drug use and pharmacy records in a population-based study in The Netherlands. Pharm World Sci. 1999;21:217-220. (Pubitemid 29485013)
25. Margolis KL, Lihong Q, Brzyski R, Bonds DE, Howard BV, Kempainen S, Simin L, Robinson JG, Safford MM, Tinker LT, Phillips LS. Validity of diabetes self-reports in the Women's Health Initiative: comparison with medication inventories and fasting glucose measurements. Clin Trials. 2008;5:240-247.
26. Lipworth L, Fryzek JP, Fored CM, Blot WJ, McLaughlin JK. Comparison of surrogate with self-respondents regarding medical history and prior medication use. Int J Epidemiol. 2001;30:303-308. (Pubitemid 32447832)
27. Vernon SW, Tiro JA, Vojvodic RW, Coan S, Diamond PM, Greisinger A, Fernandez ME. Reliability and validity of a questionnaire to measure colorectal cancer screening behaviors: does mode of survey administration matter? Cancer Epidemiol Biomarkers Prev. 2008;17: 758-767. (Pubitemid 351536403)